BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30594037)

  • 1. Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer.
    Zhang W; Zhang J; Zhang Z; Guo Y; Wu Y; Wang R; Wang L; Mao S; Yao X
    Transl Oncol; 2019 Mar; 12(3):485-492. PubMed ID: 30594037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancer.
    Tsai YS; Jou YC; Tsai HT; Cheong IS; Tzai TS
    Urol Oncol; 2019 Nov; 37(11):810.e17-810.e27. PubMed ID: 31253481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1.
    Zhang W; Mao S; Shi D; Zhang J; Zhang Z; Guo Y; Wu Y; Wang R; Wang L; Huang Y; Yao X
    Front Oncol; 2019; 9():619. PubMed ID: 31355138
    [No Abstract]   [Full Text] [Related]  

  • 4. Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma.
    Kozuma Y; Takada K; Toyokawa G; Kohashi K; Shimokawa M; Hirai F; Tagawa T; Okamoto T; Oda Y; Maehara Y
    Eur J Cancer; 2018 Sep; 101():20-29. PubMed ID: 30014971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H
    Yang D; Li T; Li Y; Zhang S; Li W; Liang H; Xing Z; Du L; He J; Kuang C; Yang Q
    J Exp Clin Cancer Res; 2019 Feb; 38(1):88. PubMed ID: 30777103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma.
    Xu M; Zhu F; Yin Q; Yin H; Fang S; Luo G; Huang J; Huang W; Liu F; Zhong M; Deng X
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role and Mechanism of S1PR5 in Colon Cancer.
    Zhou H; Yin X; Bai F; Liu W; Jiang S; Zhao J
    Cancer Manag Res; 2020; 12():4759-4775. PubMed ID: 32606966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
    Yang X; Shi L; Yi C; Yang Y; Chang L; Song D
    Int J Urol; 2018 Feb; 25(2):157-163. PubMed ID: 29117631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.
    Huang C; Yang G; Jiang T; Zhu G; Li H; Qiu Z
    Neoplasma; 2011; 58(5):396-405. PubMed ID: 21744993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
    Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
    BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene silencing of indoleamine 2,3-dioxygenase 1 inhibits lung cancer growth by suppressing T-cell exhaustion.
    Shang K; Wang Z; Hu Y; Huang Y; Yuan K; Yu Y
    Oncol Lett; 2020 Jun; 19(6):3827-3838. PubMed ID: 32382333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2,3-Dioxygenase-1 Expression is Changed During Bladder Cancer Cell Invasion.
    Santos HJSP; Matheus LHG; Silva A; Dalmazzo SV; Santos AA; Santos LRAR; Souza DM; Reis ST; Nascimento IP; Dellê H
    Int J Tryptophan Res; 2022; 15():11786469211065612. PubMed ID: 35002253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/Autoimmunity.
    El-Zaatari M; Bass AJ; Bowlby R; Zhang M; Syu LJ; Yang Y; Grasberger H; Shreiner A; Tan B; Bishu S; Leung WK; Todisco A; Kamada N; Cascalho M; Dlugosz AA; Kao JY
    Gastroenterology; 2018 Jan; 154(1):140-153.e17. PubMed ID: 28912017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer.
    Rosenberg AJ; Wainwright DA; Rademaker A; Galvez C; Genet M; Zhai L; Lauing KL; Mulcahy MF; Hayes JP; Odell DD; Horbinski C; Komanduri S; Tetreault MP; Kim KA; Villaflor VM
    Oncotarget; 2018 May; 9(34):23482-23493. PubMed ID: 29805749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers.
    Komiya T; Huang CH
    Front Oncol; 2018; 8():423. PubMed ID: 30338242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway.
    Xu X; Yang C; Chen J; Liu J; Li P; Shi Y; Yu P
    Biochem Biophys Res Commun; 2018 May; 499(2):273-278. PubMed ID: 29574157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
    Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
    Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY; Chang SF; Liao KF; Chiu SC
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.